z-logo
open-access-imgOpen Access
P575 Vedolizumab trough levels predict clinical outcomes in inflammatory bowel disease
Author(s) -
Luisa Guidi,
Daniela Pugliese,
Tommaso Panici Tonucci,
Barbara Tolusso,
Carla Felice,
Clara Di Mario,
Alfredo Papa,
Elisa Gremese,
Antonio Gasbarrini,
G.L. Rapaccini,
Alessandro Armuzzi
Publication year - 2018
Publication title -
journal of crohn s and colitis
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.277
H-Index - 80
eISSN - 1876-4479
pISSN - 1873-9946
DOI - 10.1093/ecco-jcc/jjx180.702
Subject(s) - vedolizumab , medicine , ulcerative colitis , gastroenterology , inflammatory bowel disease , concomitant , receiver operating characteristic , area under the curve , mann–whitney u test , trough level , crohn's disease , disease , transplantation , tacrolimus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom